KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Insulet (PODD) EBITDA (2016 - 2025)

Historic EBITDA for Insulet (PODD) over the last 17 years, with Q3 2025 value amounting to $117.7 million.

  • Insulet's EBITDA rose 3359.82% to $117.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $436.9 million, marking a year-over-year increase of 4282.45%. This contributed to the annual value of $308.9 million for FY2024, which is 4040.91% up from last year.
  • Insulet's EBITDA amounted to $117.7 million in Q3 2025, which was up 3359.82% from $121.1 million recorded in Q2 2025.
  • Insulet's 5-year EBITDA high stood at $121.1 million for Q2 2025, and its period low was -$26.7 million during Q2 2022.
  • In the last 5 years, Insulet's EBITDA had a median value of $49.7 million in 2021 and averaged $53.7 million.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 20152.09% in 2022, then surged by 178965.52% in 2023.
  • Insulet's EBITDA (Quarter) stood at $49.7 million in 2021, then crashed by 52.72% to $23.5 million in 2022, then skyrocketed by 352.77% to $106.4 million in 2023, then increased by 2.73% to $109.3 million in 2024, then increased by 7.69% to $117.7 million in 2025.
  • Its EBITDA stands at $117.7 million for Q3 2025, versus $121.1 million for Q2 2025 and $88.8 million for Q1 2025.